Prokineticin 1 Protein (Prok1)
-
- Target Alle Prokineticin 1 (Prok1) Proteine anzeigen
- Prokineticin 1 (Prok1)
- Protein-Typ
- Recombinant
-
Spezies
- Human
-
Quelle
- Escherichia coli (E. coli)
- Produktmerkmale
-
Purified recombinant Human EG VEGF protein
Expression System: E.coli - Reinheit
- > 97 % pure
- Top Product
- Discover our top product Prok1 Protein
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Reconstitute in distilled water to a concentration > 0.1 mg/mL.
- Buffer
- Supplied lyophilized from a concentrated (1 mg/mL) solution, with no additives.
- Konservierungsmittel
- Without preservative
- Handhabung
- Avoid repeated freeze/thaw cycles.
- Lagerung
- RT/-20 °C
-
- Target
- Prokineticin 1 (Prok1)
- Andere Bezeichnung
- EG VEGF (Prok1 Produkte)
- Hintergrund
-
Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) induces proliferation, migration, and fenestration in capillary endothelial cells derived from endocrine glands. Its expression is induced by hypoxia and is restricted to the steroidogenic glands (ovary, testis, adrenal, and placenta). Its expression is often complementary to the expression of VEGF (MIM 192240), suggesting that these molecules function in a coordinated manner. EG-VEGF potently contracts gastrointestinal (gi) smooth muscle. Induces proliferation, migration and fenestration (the formation of membrane discontinuities) in capillary endothelial cells derived from endocrine glands. Has little or no effect on a variety of other endothelial and non-endothelial cell types.
Alternative Names: PK1 protein, Endocrine Gland-derived Vascular Endothelial Growth Factor protein, PRK1 protein, EG-VEGF protein, Prokineticin 1 protein
-